Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Comparison Between Full Thickness and Partial Thickness Corneal Transplantation for Corneal Edema
This study is currently recruiting participants.
Verified by Mayo Clinic, June 2006
Sponsored by: Mayo Clinic
Information provided by: Mayo Clinic
ClinicalTrials.gov Identifier: NCT00346138
  Purpose

The objectives of this study are to compare the visual and refractive outcomes of deep lamellar endothelial keratoplasty (DLEK) with penetrating keratoplasty as treatment for certain cases of corneal edema due to endothelial decompensation. Additionally, data will be collected to compare corneal shape, corneal thickness, endothelial cell density, keratocyte density, corneal sensitivity, light scatter, and subjective visual function between the two procedures.


Condition Intervention
Fuch's Dystrophy
Corneal Edema
Procedure: Corneal transplantation

Genetics Home Reference related topics: Lenz microphthalmia syndrome oculofaciocardiodental syndrome Peters plus syndrome
MedlinePlus related topics: Edema
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Single Group Assignment
Official Title: Deep Lamellar Endothelial Keratoplasty as Surgical Treatment for Corneal Endothelial Decompensation

Further study details as provided by Mayo Clinic:

Primary Outcome Measures:
  • Visual acuity.

Secondary Outcome Measures:
  • Astigmatism
  • contrast sensitivity
  • corneal haze
  • endothelial cell density
  • corneal thickness

Estimated Enrollment: 50
Study Start Date: June 2005
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  1. Corneal edema due to endothelial dysfunction
  2. Aphakia, pseudophakia, or cataract requiring extraction
  3. Visual acuity in a) study eye; best spectacle-corrected entrance acuity 20/40 or worse. b)contralateral eye; best spectacle-corrected entrance acuity equal to or better than the study eye and 20/200 or better.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00346138

Locations
United States, Minnesota
Mayo Clinic Recruiting
Rochester, Minnesota, United States, 55905
Contact: Keith H. Baratz, M.D.         baratz.keith@mayo.edu    
Principal Investigator: Keith H. Baratz, M.D.            
Sponsors and Collaborators
Mayo Clinic
Investigators
Principal Investigator: Keith H. Baratz, M.D. Mayo Clinic
  More Information

Publications indexed to this study:
Study ID Numbers: 1000-03
Study First Received: June 27, 2006
Last Updated: June 27, 2006
ClinicalTrials.gov Identifier: NCT00346138  
Health Authority: United States: Institutional Review Board

Study placed in the following topic categories:
Signs and Symptoms
Corneal Diseases
Corneal dystrophy
Genetic Diseases, Inborn
Corneal Dystrophies, Hereditary
Eye Diseases
Corneal dystrophy, Fuchs' endothelial, 1
Fuchs' Endothelial Dystrophy
Corneal Edema
Eye Diseases, Hereditary
Edema

ClinicalTrials.gov processed this record on January 14, 2009